Abstract
This study focuses on the photoluminescence properties of loracarbef (LOR) ligand and its [Zn(LOR) (H2O)(Cl)]Cl, [Cd(LOR)(H2O)(Cl)]Cl, [Ni(LOR)(H2O)(Cl)]Cl, [Pd(LOR)(H2O)(AcO)]AcO and [Pt(LOR)(H2O)(Cl)]Cl complexes. LOR and the resulting metal complexes gave an intense emission (where λmax = 376 nm) upon irradiation by Ultra-Violet light. The photoluminescence quantum yields and long excited-state lifetimes of the ligand and its complexes were calculated. The LOR ligand has a photoluminescence quantum yield of 52% and long excited-state lifetime of 4.88 ns. The photoluminescence intensities and quantum yields of the metal complexes dramatically reduced with respect to that of the LOR ligand upon complexation with various metals. The structures of new complexes were characterized using spectroscopic techniques including FT-IR, electronic spectra, 1H-NMR and mass spectral data. In addition, all complexes were screened for antibacterial activity against several bacteria and yeasts, and results were compared with those of LOR.
Keywords: Loracarbef, Metal complex, Photoluminescence, Antimicrobial activity
Current Analytical Chemistry
Title: Preparation, Photoluminescence and Antimicrobial Activity of Loracarbef and its Various Complexes
Volume: 5 Issue: 4
Author(s): Huseyin Zengin, Mustafa Dolaz and Aysegul Golcu
Affiliation:
Keywords: Loracarbef, Metal complex, Photoluminescence, Antimicrobial activity
Abstract: This study focuses on the photoluminescence properties of loracarbef (LOR) ligand and its [Zn(LOR) (H2O)(Cl)]Cl, [Cd(LOR)(H2O)(Cl)]Cl, [Ni(LOR)(H2O)(Cl)]Cl, [Pd(LOR)(H2O)(AcO)]AcO and [Pt(LOR)(H2O)(Cl)]Cl complexes. LOR and the resulting metal complexes gave an intense emission (where λmax = 376 nm) upon irradiation by Ultra-Violet light. The photoluminescence quantum yields and long excited-state lifetimes of the ligand and its complexes were calculated. The LOR ligand has a photoluminescence quantum yield of 52% and long excited-state lifetime of 4.88 ns. The photoluminescence intensities and quantum yields of the metal complexes dramatically reduced with respect to that of the LOR ligand upon complexation with various metals. The structures of new complexes were characterized using spectroscopic techniques including FT-IR, electronic spectra, 1H-NMR and mass spectral data. In addition, all complexes were screened for antibacterial activity against several bacteria and yeasts, and results were compared with those of LOR.
Export Options
About this article
Cite this article as:
Zengin Huseyin, Dolaz Mustafa and Golcu Aysegul, Preparation, Photoluminescence and Antimicrobial Activity of Loracarbef and its Various Complexes, Current Analytical Chemistry 2009; 5 (4) . https://dx.doi.org/10.2174/157341109789077777
DOI https://dx.doi.org/10.2174/157341109789077777 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pyrrolocarbazoles as Checkpoint 1 Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry High-throughput Strategy Accelerates the Progress of Marine Anticancer Peptide Drug Development
Recent Patents on Anti-Cancer Drug Discovery Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition
Anti-Cancer Agents in Medicinal Chemistry Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis
Current Medicinal Chemistry Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization
Current Drug Delivery Recent Advances in Design of Immunogenic and Effective Naked DNA Vaccines Against Cancer
Recent Patents on Anti-Cancer Drug Discovery p42.3: An Abductor of Cell Cycle
Anti-Cancer Agents in Medicinal Chemistry Preface
Current Cancer Drug Targets Glioblastoma Tumor Initiating Cells: Therapeutic Strategies Targeting Apoptosis and MicroRNA Pathways
Current Molecular Medicine Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Urtica dioica Extract Inhibits Cell Proliferation and Induces Apoptosis in HepG2 and HTC116 as Gastrointestinal Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Receptor Binding Inhibitor Suppresses Carcinogenesis of Cervical Cancer by Depressing Levels of FSHR and ERβ in Mice
Anti-Cancer Agents in Medicinal Chemistry New Potential Pharmaceutical Applications of Hypericum Species
Mini-Reviews in Medicinal Chemistry Benzoin Schiff Bases: Design, Synthesis, and Biological Evaluation as Potential Antitumor Agents
Medicinal Chemistry Antioxidant Vitamins and Cardiovascular Disease
Current Topics in Medicinal Chemistry Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs
Current Pharmaceutical Design Functional Genomics Approaches in Cancer Research
Current Genomics Editorial (Thematic Issue: New Therapeutic Approaches for the Treatment of Glioblastoma)
Current Cancer Drug Targets Current Prevention and Treatment of Postoperative Nausea and Vomiting after Gynecological Laparoscopic Surgery
Current Drug Therapy Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
Current Medicinal Chemistry